Ayurvedic Approach to SIBO Treatment: Natural Remedies and Insights

Small Intestinal Bacterial Overgrowth — commonly known as SIBO — is a digestive condition where bacteria that normally live in the large intestine migrate and multiply excessively in the small intestine. This overgrowth disrupts normal digestion and nutrient absorption, causing symptoms like bloating, gas, abdominal pain, diarrhea, and fatigue. SIBO affects an estimated 2.5% to 22% of the general population, and research suggests that up to 78% of patients diagnosed with Irritable Bowel Syndrome (IBS) test positive for SIBO on breath testing. If left untreated, SIBO can lead to serious nutritional deficiencies and long-term complications.

This comprehensive guide covers everything you need to know about SIBO — from the root causes and early warning signs to accurate diagnostic methods, evidence-based treatments (including the often-overlooked elemental diet and prokinetic therapies), and practical strategies to prevent the frustratingly common recurrences. We also explain the critical difference between hydrogen-dominant SIBO and the newly reclassified Intestinal Methanogen Overgrowth (IMO), something most resources fail to address properly.

What Is SIBO and How Does It Develop?

• Your gastrointestinal tract is home to trillions of microorganisms.
• The vast majority of these bacteria — roughly 99% — are supposed to reside in the large intestine (colon). The small intestine, by contrast, normally maintains relatively low bacterial counts, typically fewer than 10³ colony-forming units per milliliter (CFU/mL). SIBO is diagnosed when the bacterial population in the small intestine exceeds 10⁵ CFU/mL, or when colonic-type bacteria are detected in the small bowel.

The small intestine is where most nutrient absorption takes place. When excessive bacteria colonize this region, they begin fermenting carbohydrates before your body can absorb them, producing hydrogen and other gases. They also interfere with fat absorption by deconjugating bile acids and compete with your body for essential nutrients like vitamin B12.

How the Body Normally Prevents Bacterial Overgrowth

Your body has several built-in defense mechanisms designed to keep small intestinal bacteria counts low:

• Gastric acid — Stomach acid kills most ingested bacteria before they reach the small intestine
• Migrating Motor Complex (MMC) — A "cleansing wave" of peristaltic contractions that sweeps bacteria and debris from the small intestine during fasting periods (roughly every 90-120 minutes)
• Ileocecal valve — A physical barrier preventing backflow of colonic bacteria into the small intestine
• Secretory IgA — Immune antibodies that neutralize and clear bacteria from the small intestinal lining
• Bile and pancreatic enzymes — These have antimicrobial properties that help regulate bacterial populations

When one or more of these mechanisms fail, bacteria accumulate in the small intestine and SIBO develops.

SIBO vs IMO: A Critical Distinction Most Resources Miss

Modern gastroenterology now recognizes that not all "SIBO" is the same. The traditional understanding focused on hydrogen-producing bacteria. However, methane production in the gut comes from archaea (primarily Methanobrevibacter smithii), which are not bacteria at all — they're a completely separate domain of microorganisms.

This has led to an important reclassification:

This distinction matters enormously for treatment. A patient with methane-dominant symptoms who is treated with rifaximin alone — the standard SIBO protocol — may see limited improvement because archaea require combination antibiotic therapy. Many clinicians and online resources still lump these together, which contributes to treatment failures and frustration.

A third subtype, hydrogen sulfide-dominant SIBO, has also been identified through newer trio-gas breath testing, though diagnostic tools for this variant remain less widely available.

What Are the Signs and Symptoms of SIBO?

SIBO symptoms can range from mildly annoying to seriously debilitating. The hallmark presentation involves chronic digestive complaints that often overlap with IBS — which is exactly why misdiagnosis is so common.

Core Digestive Symptoms

The most frequently reported symptoms include:

• Bloating and abdominal distension — often described as looking "six months pregnant" by afternoon, even after small meals
• Excessive gas and flatulence — caused by bacterial fermentation of carbohydrates
• Abdominal pain or cramping — typically worse after eating, often periumbilical (around the navel)
• Diarrhea — more common in hydrogen-dominant SIBO
• Constipation — more common in methane-dominant IMO
• Nausea — especially after meals
• Early satiety — feeling uncomfortably full after eating very little
• Acid reflux or belching

What Does SIBO Stool Look Like?

This is one of the most commonly searched questions, and for good reason — changes in stool can be an early clue.

SIBO stool may present as:

• Oily, greasy, or floating stools (steatorrhea) — resulting from fat malabsorption due to bile acid deconjugation
• Pale or clay-colored stools — another sign of impaired fat digestion
• Mucus in the stool — indicating intestinal inflammation
• Thin, pencil-like stools — sometimes seen with methane-dominant IMO due to slowed motility
• Foul-smelling stools — from bacterial putrefaction of undigested nutrients

Some patients alternate between diarrhea and constipation, making it especially difficult to distinguish from mixed-type IBS without proper testing.

Systemic Symptoms Beyond the Gut

SIBO doesn't just affect your digestion. Because the small intestine is where most nutrients are absorbed, bacterial overgrowth can cause widespread systemic problems:

• Chronic fatigue and brain fog — linked to nutrient depletion and systemic inflammation
• Unexplained weight loss — from malabsorption of calories and macronutrients
• Joint pain — potentially driven by increased intestinal permeability ("leaky gut") and systemic inflammation
• Skin problems — including rosacea, acne, and eczema; a 2008 study in Clinical Gastroenterology and Hepatology found a significant association between SIBO and rosacea
• Depression and anxiety — increasingly linked to gut-brain axis dysfunction

What Is the Root Cause of SIBO?

SIBO is almost never a primary disease. Its always a consequence of some underlying condition or event that has compromised one or more of the body's natural defenses against bacterial overgrowth. Identifying and addressing this root cause is the single most important step in successful treatment — and in preventing recurrence.

Impaired Motility: The Most Common Culprit

Dysmotility — reduced or discoordinated movement of the small intestine — is the leading cause of SIBO. When the Migrating Motor Complex (MMC) doesn't function properly, bacteria aren't swept through efficiently and begin to accumulate.

Conditions that impair motility include:

• Diabetes mellitus — diabetic neuropathy can damage the nerves controlling gut motility
• Hypothyroidism — thyroid hormone is essential for normal GI motility
• Scleroderma and connective tissue disorders — can cause fibrosis of intestinal smooth muscle
• Post-infectious IBS — food poisoning (particularly from Campylobacter jejuni, Salmonella, and E. coli) can trigger an autoimmune response that damages vinculin, a protein essential for MMC function. This mechanism, first described by Dr. Mark Pimentel's research at Cedars-Sinai, explains why many patients can trace their SIBO onset to a single episode of acute gastroenteritis
• Chronic opioid use — opioids dramatically slow intestinal motility
• Ehlers-Danlos Syndrome — increasingly recognized as a risk factor for SIBO through its effects on connective tissue and motility

Structural and Anatomical Causes

• Surgical alterations — gastric bypass, Roux-en-Y, ileocecal valve resection, or any procedure creating blind loops
• Small bowel strictures — from Crohn's disease, radiation, or adhesions
• Small bowel diverticula — creating pockets where bacteria can stagnate

Reduced Gastric Acid and Immune Deficiency

• Proton pump inhibitors (PPIs) — long-term use significantly increases SIBO risk. A 2013 meta-analysis published in the Journal of Gastroenterology found that PPI use was associated with a 2.7-fold increased risk of SIBO
• Chronic atrophic gastritis — reduced acid production
• IgA deficiency — impaired mucosal immune defense
• HIV/AIDS and other immunocompromised states

Other Risk Factors

How Is SIBO Diagnosed?

• Accurate diagnosis is essential because SIBO symptoms overlap heavily with IBS, lactose intolerance, celiac disease, and other GI conditions.
• Unfortunately, there is no single perfect test — but several diagnostic approaches exist, each with strengths and limitations.

The Hydrogen-Methane Breath Test

The lactulose or glucose breath test is the most widely used, non-invasive method for diagnosing SIBO.

Here's how it works:

• 1.Preparation — The patient follows a restricted diet (white rice, plain meat, clear liquids) for 24 hours and fasts overnight for 12 hours
• 2.Baseline measurement — A baseline breath sample is collected
• 3.Sugar substrate — The patient drinks a lactulose or glucose solution
• 4.Serial measurements — Breath samples are collected every 15-20 minutes for 2-3 hours
• 5.Interpretation — The lab measures hydrogen, methane, and (in newer tests) hydrogen sulfide levels

Diagnostic criteria (North American Consensus, 2017):

• Hydrogen-dominant SIBO: Rise in hydrogen ≥20 parts per million (ppm) from baseline within 90 minutes
• Methane/IMO: Methane level ≥10 ppm at any point during the test

Glucose vs Lactulose: Which Is Better?

• Glucose breath test — Higher specificity (~80-90%) but only detects overgrowth in the proximal (upper) small intestine, as glucose is absorbed before reaching the distal ileum
• Lactulose breath test — Can detect overgrowth throughout the entire small intestine but has a higher false-positive rate (~30%) because lactulose naturally reaches the colon

Neither test is perfect. False negatives occur, particularly with hydrogen sulfide-dominant SIBO, which standard two-gas tests cannot detect.

Small Bowel Aspirate and Culture

Jejunal aspirate obtained during upper endoscopy with direct bacterial culture was traditionally considered the "gold standard." A bacterial count exceeding 10⁵ CFU/mL is diagnostic.

However, this method is:

• Invasive and expensive
• Subject to contamination during the procedure
• Unable to culture all bacterial species (many are anaerobes that dont grow in standard culture media)
• Only samples a small segment of the small intestine

For these reasons, breath testing has become the practical first-line diagnostic tool in most clinical settings.

Supporting Blood and Stool Tests

While not diagnostic for SIBO directly, the following tests can reveal consequences of bacterial overgrowth and support the diagnosis:

• Serum vitamin B12 — often low (bacteria consume B12)
• Serum folate — often normal or elevated (bacteria produce folate)
• Fat-soluble vitamins (A, D, E, K) — may be depleted due to fat malabsorption
• Iron studies and complete blood count — may reveal iron-deficiency anemia
• Fecal fat test — elevated in steatorrhea
• Anti-vinculin and anti-CdtB antibodies — relatively newer blood tests that can help confirm post-infectious SIBO/IBS; these autoantibodies attack proteins involved in gut motility

The combination of a low B12 with a normal or elevated folate level is considered a classic laboratory signature of SIBO.

SIBO Treatment: Antibiotics, Diet, and Beyond

Effective SIBO treatment requires a three-pronged approach: (1) reducing the bacterial overgrowth, (2) addressing the root cause, and (3) correcting nutritional deficiencies. Simply killing bacteria with antibiotics without fixing the underlying problem is the primary reason SIBO recurs — and it recurs frequently. Research shows approximately 44% of patients experience recurrence within 9 months of successful antibiotic treatment.

Antibiotic Therapy: The First-Line Approach

Rifaximin (brand name Xifaxan) is the most studied and preferred antibiotic for SIBO. It's a non-systemic antibiotic, meaning it stays in the gut and has minimal systemic side effects.

Standard Treatment Protocols with Dosages

This is one of the most significant gaps in existing online resources — most articles mention rifaximin but fail to provide specific dosages or acknowledge that methane-dominant cases require combination therapy. If your clinician prescribes rifaximin alone for methane-positive SIBO, it's worth discussing the evidence for adding a second agent.

Eradication rates with rifaximin monotherapy average around 50-70%. Adding neomycin for methane cases improves efficacy significantly — a 2014 study by Pimentel et al. showed an 85% normalization rate for methane on breath testing with the combination versus 33% with rifaximin alone.

The Elemental Diet: A Powerful Alternative Nobody Talks About

Here's something none of the top-ranking articles for SIBO adequately cover — the elemental diet. This is a liquid diet consisting of pre-digested nutrients (amino acids, simple sugars, fats, vitamins, and minerals) that are absorbed in the very upper portion of the small intestine, effectively starving bacteria further down.

A landmark 2004 study by Pimentel et al. published in Digestive Diseases and Sciences found that a 14-day elemental diet normalized lactulose breath testing in 80-85% of patients — a higher eradication rate than antibiotic therapy.

The elemental diet is particularly valuable for:

• Patients who cannot tolerate antibiotics
• Antibiotic-resistant cases
• Patients who prefer a non-pharmaceutical approach
• Severe cases requiring aggressive intervention

The main drawbacks? It tastes unpleasant (though flavored formulations have improved), its expensive, and 14 days of consuming nothing but an elemental formula requires serious commitment. But for refractory SIBO, it remains one of the most effective tools available.

What Foods Trigger SIBO? The Role of Diet

Diet alone doesn't cause SIBO, but certain foods feed the bacteria and dramatically worsen symptoms.

The most common trigger foods include:

• High-FODMAP foods — fermentable oligosaccharides, disaccharides, monosaccharides, and polyols
• Sugar and artificial sweeteners — rapidly fermented by bacteria
• Dairy products — lactose fermentation produces gas
• Grains and wheat-based products
• Starchy vegetables — potatoes, corn
• High-fructose fruits — apples, pears, watermelon, mangoes
• Legumes and beans
• Garlic and onions — high in fructans

The Low-FODMAP Diet for SIBO

The Low-FODMAP diet, developed at Monash University, is the most evidence-based dietary approach for managing SIBO symptoms. It reduces the fermentable substrates available to bacteria.

The protocol involves:

• 1.Elimination phase (2-6 weeks) — Strictly avoid high-FODMAP foods
• 2.Reintroduction phase (6-8 weeks) — Systematically reintroduce FODMAP groups to identify personal triggers
• 3.Personalization phase (ongoing) — Follow a modified diet based on individual tolerances

Important: The Low-FODMAP diet is a symptom management tool, not a cure. It reduces the fuel available to bacteria, but it doesn't eradicate the overgrowth. It works best when combined with antimicrobial treatment.

Other dietary approaches that some practitioners use include the Specific Carbohydrate Diet (SCD), the Bi-Phasic Diet (developed by Dr. Nirala Jacobi), and the SIBO-Specific Food Guide.

Prokinetics: The Missing Piece for Preventing Recurrence

This is arguably the most critical gap in SIBO management — and almost no online resource addresses it adequately. Prokinetics are medications that stimulate the Migrating Motor Complex (MMC), which is the "sweeping wave" that keeps bacteria from accumulating in the small intestine.

Since impaired motility is the most common root cause of SIBO, prokinetics serve as long-term maintenance therapy after antibiotic eradication. Without them, recurrence rates remain stubbornly high.

Commonly used prokinetics for SIBO prevention:

Prokinetics are typically started immediately after completing antibiotic treatment and continued for 3-6 months minimum. Some patients with irreversible motility disorders may need indefinite prokinetic therapy.

Correcting Nutritional Deficiencies

SIBO frequently causes specific nutrient depletions that need active supplementation:

• Vitamin B12 — sublingual or intramuscular injections (oral B12 may be poorly absorbed)
• Iron — monitor ferritin levels; IV iron may be needed in severe cases
• Fat-soluble vitamins (A, D, E, K) — supplement based on serum levels; use emulsified forms for better absorption
• Calcium and magnesium — due to fat malabsorption affecting mineral binding
• Omega-3 fatty acids — often depleted from fat malabsorption

The unique pathophysiology here is worth understanding: bacteria in the small intestine consume vitamin B12 for their own metabolic needs while simultaneously producing folate as a metabolic byproduct. This explains the classic SIBO laboratory pattern of low B12 with normal-to-high folate. Additionally, bacterial deconjugation of bile acids impairs the formation of micelles necessary for fat absorption, leading to deficiencies of fat-soluble vitamins and steatorrhea.

What Happens If SIBO Is Left Untreated?

Ignoring SIBO doesn't make it go away. Without treatment, the condition tends to worsen progressively, and the complications can be severe:

• Severe malnutrition and macronutrient deficiency — protein-calorie malnutrition in advanced cases
• Megaloblastic anemia — from B12 deficiency
• Iron-deficiency anemia — from impaired iron absorption
• Osteoporosis and osteomalacia — from vitamin D and calcium malabsorption
• Peripheral neuropathy — numbness, tingling, and nerve damage from prolonged B12 deficiency
• Night blindness — from vitamin A deficiency
• Easy bruising and bleeding — from vitamin K deficiency
• Kidney stones — from increased oxalate absorption (normally oxalate binds to calcium in the gut; when calcium is malabsorbed, free oxalate is absorbed and excreted by the kidneys)
• Increased intestinal permeability — bacterial overgrowth damages tight junctions between enterocytes, potentially contributing to systemic inflammation and autoimmune activation
• D-lactic acidosis — a rare but serious complication where bacteria produce D-lactic acid, causing neurological symptoms including confusion and ataxia

Histopathological examination of the small intestinal mucosa in SIBO patients can reveal villous atrophy, crypt hyperplasia, intraepithelial lymphocytosis, eosinophilic infiltration, and mucosal edema — changes that can mimic celiac disease on biopsy and sometimes lead to misdiagnosis.

The Gut-Brain Connection: How Stress and SIBO Feed Each Other

One of the most underappreciated aspects of SIBO is the role of the gut-brain axis. Your brain and your gut communicate bidirectionally through the vagus nerve, the enteric nervous system, and various hormonal and immune pathways.

• Chronic psychological stress directly impairs gut motility by reducing vagal tone — the activity of the vagus nerve that drives the Migrating Motor Complex. When the MMC slows down, bacterial clearance decreases, and SIBO risk increases.
• This creates a vicious cycle: stress causes dysmotility → dysmotility causes SIBO → SIBO causes GI symptoms → GI symptoms cause more stress and anxiety.

This mechanism also explains why some patients continue experiencing symptoms even after breath tests normalize. The dysregulated gut-brain signaling maintains symptom perception and visceral hypersensitivity independent of the bacterial count.

Interventions targeting the gut-brain axis — including gut-directed hypnotherapy, cognitive behavioral therapy (CBT), vagal nerve stimulation exercises (like deep diaphragmatic breathing and cold exposure), and mindfulness meditation — are increasingly being incorporated into comprehensive SIBO treatment plans. A randomized controlled trial published in The Lancet Gastroenterology & Hepatology (2019) showed that gut-directed hypnotherapy was as effective as the Low-FODMAP diet for IBS symptom reduction, with benefits persisting at 6-month follow-up.

The SIBO-IBS Connection: Are They the Same Thing?

SIBO and IBS share so many symptoms — bloating, abdominal pain, altered bowel habits — that distinguishing them clinically without testing is nearly impossible. But they are not the same condition.

IBS is a diagnosis of exclusion based on symptom criteria (Rome IV criteria). SIBO is a measurable, testable condition with a specific pathological mechanism.

However, the overlap is enormous:

• Studies consistently show that 30-78% of IBS patients test positive for SIBO on breath testing (the wide range reflects differences in testing methodolgy and diagnostic criteria)
• Successful SIBO treatment often leads to significant improvement in IBS symptoms
• The Rome Foundation has acknowledged that SIBO may be an underlying mechanism in a subset of IBS patients

For patients who have been told they "just have IBS" and haven't responded to conventional IBS treatments, SIBO breath testing is a logical and worthwile next step.

Frequently Asked Questions About SIBO

Does SIBO Go Away on Its Own?

No. SIBO rarely resolves spontaneously because the underlying conditions that caused it — impaired motility, structural abnormalities, reduced acid production — typically persist. Without treatment, SIBO tends to become chronic and progressively cause worsening symptoms and nutritional deficiencies.

Does Stress Make SIBO Worse?

Yes. Chronic stress reduces vagal nerve activity, which impairs the Migrating Motor Complex and slows gut motility. This creates conditions favorable for bacterial overgrowth and worsens existing SIBO. Stress also increases visceral hypersensitivity, meaning you perceive gut sensations as more painful.

Do Probiotics Help With SIBO?

• This is controversial. The logic of adding more bacteria to a condition defined by bacterial overgrowth seems counterintuitive.
• However, some strains — particularly Saccharomyces boulardii (a yeast, not a bacterium) and soil-based organisms — may be helpful as adjunct therapy. A 2017 meta-analysis in the Journal of Clinical Gastroenterology found that probiotics reduced bacterial overgrowth and abdominal pain in SIBO patients, though the quality of evidence was low. Most SIBO specialists recommend avoiding multi-strain, high-CFU probiotics during active treatment and considering targeted probiotic therapy during the maintenance phase.

How Long Does SIBO Recovery Take?

• A single round of antibiotic therapy takes 14 days, but full recovery is longer. Most patients begin feeling symptom improvement within the first week of treatment.
• Complete resolution of symptoms — including reversal of nutritional deficiencies and restoration of normal gut function — typically takes 2-6 months. Patients with longstanding SIBO, significant mucosal damage, or ongoing root causes may require longer recovery periods, multiple treatment rounds, and sustained prokinetic therapy.

What Naturally Kills SIBO?

• Herbal antimicrobials have shown promise as alternatives to pharmaceutical antibiotics. A 2014 study published in Global Advances in Health and Medicine by Johns Hopkins researchers found that herbal therapy was as effective as rifaximin for SIBO eradication. Commonly used herbal antimicrobials include berberine-containing herbs, oregano oil, neem, allicin (from garlic), and Atractylodes combined with other botanicals.
• Herbal protocols typically run 4-6 weeks — longer than antibiotic courses. The elemental diet, as discussed above, is another non-pharmaceutical approach with high efficacy.

Can SIBO Cause Weight Gain?

• While weight loss from malabsorption is more commonly discussed, methane-dominant SIBO (IMO) has been associated with weight gain. Methane slows intestinal transit time, which increases caloric extraction from food. A 2012 study showed that subjects with methane on breath testing had a significantly higher BMI than those without.
• So yes — SIBO can cause both weight loss and weight gain, depending on the subtype.

Taking Control of SIBO: Your Next Steps

• SIBO is a complex, often frustrating condition — but it is treatable.
• The key is approaching it systematically: get properly tested (ideally with a three-gas breath test that includes hydrogen sulfide), identify your subtype, treat with the appropriate protocol, address the root cause, use prokinetics to maintain motility, and give your gut time to heal.

If you've been struggling with chronic bloating, unexplained digestive issues, or an IBS diagnosis that hasn't responded to treatment, talk to a gastroenterologist experienced in SIBO about breath testing. The right diagnosis changes everything.

• Don't wait for symptoms to worsen. The longer SIBO goes untreated, the greater the risk of nutritional deficiencies and complications that become harder to reverse.
• Early, targeted intervention — combined with ongoing motility support and dietary awareness — gives you the best chance at lasting relief.

Scientific Sources

1. Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO?A Randomized Clinical Trial — Redondo-Cuevas L et al., 2024, Nutrients
2. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth — Chedid V et al., 2014, Global advances in health and medicine
3. Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review — Nickles MA et al., 2021, Journal of alternative and complementary medicine (New York, N.Y.)
4. An Oral Botanical Supplement Improves Small Intestinal Bacterial Overgrowth (SIBO) and Facial Redness: Results of an Open-Label Clinical Study — Min M et al., 2024, Nutrients
5. Should We Treat SIBO Patients? Impact on Quality of Life and Response to Comprehensive Treatment: A Real-World Clinical Practice Study — Liébana-Castillo AR et al., 2025, Nutrients
6. IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions — Šuran J et al., 2026, Antibiotics (Basel, Switzerland)
7. Chinese herbal medicine for the treatment of small intestinal bacterial overgrowth (SIBO): A protocol for systematic review and meta-analysis — Ren X et al., 2020, Medicine
8. Unravelling the controversy with small intestinal bacterial overgrowth — Shah A et al., 2023, Current opinion in gastroenterology
9. The Efficacy and Potential Mechanisms of Chinese Herbal Medicine on Irritable Bowel Syndrome — Bi Z et al., 2017, Current pharmaceutical design
10. Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations — Yu H et al., 2025, Journal of translational medicine
11. Biofilm Disruption Enhances Antimicrobial Therapy for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth — Ruscio M et al., 2025, Cureus
12. Association between Small Intestinal Bacterial Overgrowth and Subclinical Atheromatous Plaques — Dong C et al., 2022, Journal of clinical medicine
13. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview — Bokic T et al., 2015, Pharmacology
14. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth — Maeda Y et al., 2023, Antibiotics (Basel, Switzerland)
15. Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia — Shah A et al., 2022, Frontiers in neuroscience
16. Small Intestinal Bacterial Overgrowth: How to Diagnose and Treat (and Then Treat Again) — Ginnebaugh B et al., 2020, Gastroenterology clinics of North America
17. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease — Barboza JL et al., 2015, Expert opinion on pharmacotherapy
18. Single hydrogen-methane breath test for the diagnosis of small intestinal bacterial growth(https://pubmed.ncbi.nlm.nih.gov/37935501/) — Huang H et al., 2023, Zhonghua nei ke za zhi
19. Relationship among Chinese herb polysaccharide (CHP), gut microbiota, and chronic diarrhea and impact of CHP on chronic diarrhea — Xue H et al., 2023, Food science & nutrition
20. Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes — Yan LH et al., 2020, The Journal of international medical research